| Tag | Content |
|---|
EnhancerAtlas ID | HS091-25452 |
Organism | Homo sapiens |
Tissue/cell | HepG2 |
Coordinate | chr2:27315320-27317340 |
Target genes | | Number: 36 | Name | Ensembl ID |
|
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| EWSR1-FLI1 | MA0149.1 | chr2:27315582-27315600 | TTCTCCTTCCTTGCTTCC | - | 6.41 | | EWSR1-FLI1 | MA0149.1 | chr2:27315586-27315604 | CCTTCCTTGCTTCCTGCA | - | 6.62 | | FOS | MA0476.1 | chr2:27316191-27316202 | GGTGACTCATT | + | 6.02 | | MAFF | MA0495.3 | chr2:27315942-27315957 | CTGCCGACTCAGCAA | - | 6.27 | | MAFF | MA0495.3 | chr2:27315942-27315957 | CTGCCGACTCAGCAA | + | 6.2 |
|
| | Number of super-enhancer constituents: 1 | ID | Coordinate | Tissue/cell |
| SE_35436 | chr2:27314252-27320244 | HepG2 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH02I027090 | chr2 | 27313498 | 27320068 |
|
Enhancer Sequence | GTCCAGGAGG GAGAGCCCAC TGGGGAAGGC CTGCCTGCAT CATTGTGGGA GAAGAAGGAT 60
GTATCCACCC TGGGTGGATG GGGGATTAGA AATGGGTTGT GTCCAGCAGA AACGCGGGGA 120
GGGGGCATGG CGGAGCACCA GACGCCCAGC CCTGCCTTGG CGTGGCCTCT CTGCGGTTCG 180
GGGGCTGATG CTGCCCCTGT GAAGCTTTCC TTGCCACAGC TTGTTTCCTG GACACTTCTG 240
GAGCCTGCTT CAGCCTCTTC CTTTCTCCTT CCTTGCTTCC TGCAGACTCT GCGGTGGATG 300
TGCCTTTGCC TTATCTTAAG TCCCTTATCC TGGCCATGCT TGAGGCAGAA GGCAGTTAGG 360
GACACGTGGT ACCCATCCTC CCCCAGGTCC AGGCCCACAG TTTCTGTCCC AGTTGAGAGG 420
CAGGGCTGGT GCTCATGTCC CTGTTGTTCA CTGAAGCAGT GAGAGTACCC TGTTCAAGGA 480
CACCCTGAAG CCACATGCTA AAGCTGGGCT CAGAACCCAC ACCTCCCAGT TCCCCGGCTG 540
TCAGGGCTAT AGCCCTAAAT GGCTCATGCA CGCCCTCCAT GTTGGCTGCT GCAGGGACCT 600
CAGAGCCCTT TGACCCCTGG CGCTGCCGAC TCAGCAAGCA CTTATCGGGA GGTGAGGCCC 660
ACACTTTGCA CACTGTGGGC ACGGGGGCAG GCTGCCAGGT TGCTGGCCTG TGAAGGGCAG 720
CCCTTTGAAC CCTGGTTTGA AGGGGGCTGC TGGCAGAGTC CAACCACCTG AGCTACAGCC 780
AAACTCCCTG CCTTGATGAA CTGGCAGGAA GAGAATAGAG GGAGAGAATC TGCCCTGTGA 840
GATGGGACAG GACGGCTCAG AACCAAGGGC TGGTGACTCA TTAAACCTCT TTAATAGCTC 900
CTTTCCTCTG AGCTAGAGGC AGGACTGTGG CTCTGGCTTA GGATGGTCGA CTCTCCTTTA 960
CATAGCAATC AGGCCAATGG GTGGTTTATT CAGAATTCTC CCCATGTGCT CGACAAACAT 1020
TTAGAGAGCA CCTACCATGT CCCAGGCACT GGGGTGCGAA AGTTATTTGG CAAACCAAAC 1080
CATATTTCCA ATGCTTTGGG AAAGTTACTA TTTAAAGGAG TTGTAAGTCA AGGGATGATG 1140
CCCTGACTTG GTATCTTTAT GCAAATCTGT ATTATCCAGC TTTGGTGTTG CTGAAAGCGG 1200
GCTCTGGCCA GGTGAGAAAA GCCAGGATGG TGGCTGGACT GCTGGGCATA ATTGCCAGTT 1260
CTTGAGCACA GAACAATGCC TGTCCATAGA GGGCTGGAAG GGCTGGGGCT GACCTCCTTG 1320
TCCTTGCCCC TGGGCTCACT CTGCATGGAG GGCATTCCAG GAGAGAGTTC TGGACCAGGC 1380
CCATACTGAG TGGCATCAGG CACGGGGAGC CAGCTGATTG CCCAGGAGGG TTCACCTGGC 1440
TGCAGGAGGA CAAAGCAGTG AGCTGGCTCA CCAAGGCAGC ACCACTTCCA GGCTGGGCCT 1500
CCTGGAGGCA GGCAGAGAGT GAGAGGAATC ACAGCATTAG GACTGGGAGG GACTGAGAGA 1560
GGACAGCACC CTGGATGAGC TTGTGGAGGA CAGCTGGGGG CAAAGTATTG CCTTGGAGAT 1620
TAATTATTAA TCCTGTTTGG GCATTGCAGG AAACAAGCCA CGGTGCCCCC ACATGCTTGG 1680
TTCAAACAGT GTACAGGTTC TAGGGTCCTG TCTAGCTTTA TGAACAGGAG CAAATCCTTT 1740
CCAGCATGAG TTGGACTGAA AAACAGAGTC AGGATCGGAG CATGCTTCAG CCAAGACCTA 1800
AAAGGATGGC CCTTAGTGTT TCTCTCTCTG AGCTCCAGGC TCTGCACTCC TGCATCTCCT 1860
GCCCTGTTGC ACTGCCTGTG GCAAGACTGT GATTCCCAGT TCTCTCCCAG CCCCCTTTGC 1920
TTGCACCCCT GCCTTTCAGG GTCCCTAGTG GCCCTGCCAG CTACCCTCCA GTCCCCAAAA 1980
CCCTTGTCGA ACTGCACCCC CTTCGGGTTA CTCCGCCCTA 2020
|
